T. Rowe Price Associates
GILD icon

T. Rowe Price Associates’s Gilead Sciences GILD Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$2.62B Buy
23,586,692
+8,883,589
+60% +$985M 0.3% 60
2025
Q1
$1.65B Buy
14,703,103
+11,156,382
+315% +$1.25B 0.2% 94
2024
Q4
$328M Buy
3,546,721
+198,528
+6% +$18.3M 0.04% 332
2024
Q3
$281M Buy
3,348,193
+502,765
+18% +$42.2M 0.03% 367
2024
Q2
$195M Buy
2,845,428
+352,914
+14% +$24.2M 0.02% 420
2024
Q1
$183M Sell
2,492,514
-328,986
-12% -$24.1M 0.02% 436
2023
Q4
$229M Buy
2,821,500
+550,974
+24% +$44.6M 0.03% 394
2023
Q3
$170M Sell
2,270,526
-851,119
-27% -$63.8M 0.02% 420
2023
Q2
$241M Buy
3,121,645
+644,251
+26% +$49.7M 0.03% 366
2023
Q1
$206M Buy
2,477,394
+67,356
+3% +$5.59M 0.03% 378
2022
Q4
$207M Buy
2,410,038
+756,984
+46% +$65M 0.03% 373
2022
Q3
$102M Sell
1,653,054
-404,237
-20% -$24.9M 0.02% 485
2022
Q2
$127M Sell
2,057,291
-444,414
-18% -$27.5M 0.02% 593
2022
Q1
$149M Sell
2,501,705
-228,171
-8% -$13.6M 0.02% 617
2021
Q4
$198M Sell
2,729,876
-854,995
-24% -$62.1M 0.02% 558
2021
Q3
$250M Sell
3,584,871
-1,649,613
-32% -$115M 0.02% 475
2021
Q2
$360M Sell
5,234,484
-173,266
-3% -$11.9M 0.03% 412
2021
Q1
$350M Sell
5,407,750
-1,003,010
-16% -$64.8M 0.04% 405
2020
Q4
$373M Sell
6,410,760
-1,671,331
-21% -$97.4M 0.04% 382
2020
Q3
$511M Sell
8,082,091
-764,496
-9% -$48.3M 0.06% 298
2020
Q2
$681M Sell
8,846,587
-2,233,872
-20% -$172M 0.09% 242
2020
Q1
$828M Buy
11,080,459
+120,795
+1% +$9.03M 0.13% 162
2019
Q4
$712M Sell
10,959,664
-173,935
-2% -$11.3M 0.09% 239
2019
Q3
$706M Sell
11,133,599
-975,934
-8% -$61.9M 0.1% 218
2019
Q2
$818M Buy
12,109,533
+90,251
+0.8% +$6.1M 0.11% 196
2019
Q1
$781M Sell
12,019,282
-1,409,257
-10% -$91.6M 0.11% 189
2018
Q4
$840M Sell
13,428,539
-1,121,117
-8% -$70.1M 0.14% 152
2018
Q3
$1.12B Sell
14,549,656
-1,717,155
-11% -$133M 0.16% 140
2018
Q2
$1.15B Sell
16,266,811
-1,152,498
-7% -$81.6M 0.18% 130
2018
Q1
$1.31B Buy
17,419,309
+101,981
+0.6% +$7.69M 0.21% 109
2017
Q4
$1.24B Sell
17,317,328
-1,246,673
-7% -$89.3M 0.2% 114
2017
Q3
$1.5B Buy
18,564,001
+3,587,910
+24% +$291M 0.26% 93
2017
Q2
$1.06B Buy
14,976,091
+1,787,305
+14% +$127M 0.19% 123
2017
Q1
$896M Buy
13,188,786
+420,424
+3% +$28.6M 0.17% 146
2016
Q4
$914M Sell
12,768,362
-1,503,099
-11% -$108M 0.18% 134
2016
Q3
$1.13B Sell
14,271,461
-2,484,219
-15% -$197M 0.23% 105
2016
Q2
$1.4B Sell
16,755,680
-10,327,901
-38% -$862M 0.3% 74
2016
Q1
$2.49B Sell
27,083,581
-12,143,707
-31% -$1.12B 0.53% 34
2015
Q4
$3.97B Buy
39,227,288
+217,362
+0.6% +$22M 0.83% 16
2015
Q3
$3.83B Sell
39,009,926
-4,303,477
-10% -$423M 0.85% 14
2015
Q2
$5.07B Sell
43,313,403
-3,536,170
-8% -$414M 1.04% 12
2015
Q1
$4.6B Sell
46,849,573
-4,751,945
-9% -$466M 0.95% 12
2014
Q4
$4.86B Sell
51,601,518
-7,311,805
-12% -$689M 1.03% 8
2014
Q3
$6.27B Sell
58,913,323
-8,083,294
-12% -$860M 1.37% 3
2014
Q2
$5.55B Sell
66,996,617
-6,908,810
-9% -$573M 1.2% 4
2014
Q1
$5.24B Sell
73,905,427
-3,965,026
-5% -$281M 1.18% 3
2013
Q4
$5.85B Buy
77,870,453
+1,587,583
+2% +$119M 1.34% 4
2013
Q3
$4.79B Sell
76,282,870
-2,194,239
-3% -$138M 1.2% 4
2013
Q2
$4.02B Buy
+78,477,109
New +$4.02B 1.07% 5